Sales of Digene Corp.'s two-in-one test for cervical cancer jumped 66 percent in its fiscal first quarter, sending the biotechnology company's revenue and earnings higher. For the quarter ended Sept.

Digene Corp., a Gaithersburg-based maker of diagnostic tests, announced yesterday the termination of its merger with Cytyc Corp. The decision was widely expected after the Federal Trade Commission ...

Digene Gel is an over-the-counter antacid medication used to relieve symptoms associated with acidity, heartburn, and indigestion. This type of antacid is taken orally and works by neutralizing excess ...

Facing increased competition for its main product – the HPV Test – and questions about its plans for growth, Gaithersburg’s Digene Corp. agreed yesterday to be acquired by a foreign company in a $1.6 ...

The name of Joe Simons, director of the Federal Trade Commission's Bureau of Competition, was misspelled in a June 25 Business article. (Published 6/26/02) The Federal Trade Commission voted ...

The Gaithersburg company that makes the only approved test for the virus that causes cervical cancer is taking its message out of doctors’ offices and into homes nationwide. Digene Corp. is launching ...

Abbott India has recently recalled its Digene Gel product from the market after the Drug Controller General of India (DCGI) issued an advisory against its sale. Drug Controller General of India (DCGI) ...

Shares of Digene, a maker of DNA and RNA tests, sizzled on Monday after it announced that Netherlands-based Qiagen would purchase the company in a $1.6 billion deal. Digene is best known for a test to ...

QIAGEN N.V. has announced the successful completion of its acquisition of Digene Corporation. QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a ...

QIAGEN N.V. and Digene Corp. have announced a definitive agreement to combine the two companies to create market- and technology-leadership in molecular diagnostics. The Boards of Directors of both ...

The Daily Record is a digital-first daily news media company focused on law, government, business, recognition events, Power Lists, special products, public notices and more.

Deal consolidates firms’ technology in molecular diagnostics. Qiagen and Digene entered into a definitive agreement to combine the two companies to create market and technology leadership in molecular ...